IMVT Stock Analysis: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$24.30
0.32 (1.33%)
▲
5d:
-0.33%
30d:
-12.37%
90d:
-7.11%
BUY
HIGH Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Feb 18, 2026
0d
Smart Money Accumulation
IMVT is down 5.0% this week, but smart money is accumulating calls. Top strike: $30 2026-05-15 with 6,891 OI. Call ratio: 99% View Scanner →
Strength: 7.4/10
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IMVT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: IMVT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $24.30, which is considered oversold relative to its 30-day fair value range of $24.54 to $27.25.
Technical Outlook: Technically, IMVT is in a uptrend. Immediate support is located at $22.79, while resistance sits at $25.84.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.35 (+68.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IMVT is in a uptrend. Immediate support is located at $22.79, while resistance sits at $25.84.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.35 (+68.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$24.54 -
$27.25
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.3% below Wall St target ($40.35)
Fair Price Analysis
30-Day Fair Range
$24.54 -
$27.25
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$22.79
Resistance Level
$25.84
Current Trend
Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.14
Wall Street Target
$40.35
(+68.3%)
Share & Embed Analysis
Last updated: March 30, 2026 10:33 AM ET
Data refreshes hourly during market hours. Next update: 11:33 AM
Data refreshes hourly during market hours. Next update: 11:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Jay S Stout
SELL
1977 shares
2026-01-21
Jay S Stout
SELL
1203 shares
2026-01-07
Tuyl Christopher Van
SELL
10813 shares
2025-12-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 60 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.
